|
IMPORTANT NEWS REGARDING YOUR
MEDICATIONS
January 2012
Dear Patient,
If you are currently taking any
of the following medicines,
please read this important
information:
-
OPANA® ER (oxymorphone
hydrochloride)
Extended-Release Tablets CII
-
OPANA® (oxymorphone
hydrochloride) Tablets CII
-
Oxymorphone Hydrochloride
Tablets CII
-
PERCOCET® (oxycodone
hydrochloride and
acetaminophen, USP) Tablets
CII
-
PERCODAN® (oxycodone
hydrochloride and aspirin,
USP) Tablets CII
-
ENDOCET® (oxycodone
hydrochloride and
acetaminophen, USP) Tablets
CII
-
ENDODAN® (oxycodone
hydrochloride and aspirin,
USP) Tablets CII
-
Morphine Sulfate
Extended-Release Tablets CII
-
ZYDONE® (hydrocodone
bitartrate/acetaminophen
tablets, USP) CIII
Because of potential packaging
issues at the manufacturing
facility, there is a rare
possibility that a wrong tablet
may be in your bottle.
Endo is aware of only three
product mix-ups with respect to
these products since 2009, of
which all three were detected by
pharmacists. We are not aware of
any patient having experienced a
confirmed product mix-up and
there have been no adverse
events attributable to a product
mix-up. We believe the
likelihood of product mix-up
reaching a patient is remote.
As a precautionary measure, we
recommend that you:
Look at Your Medicine: We are
asking you to look carefully at
the tablets in your medicine
bottle to make sure they all
look the same.
Check Your Tablets: If you are
not sure how the tablets should
look, please refer to the visual
guide attached to this letter or
visit
www.endo.com and check your
tablets against the pictures
provided. If all the tablets in
your bottle look exactly the
same, you should continue to
take your medication as directed
by your health care
professional.
Talk to Your Pharmacist: If you
discover that any of the tablets
in your bottle are a different
color or shape from the others,
you should promptly take the
medicine back to your pharmacy
so the pharmacist can review the
contents. Your pharmacist will
be able to assist you.
Please contact Endo Customer
Service at 1-800-462-3636 if you
have any additional questions or
concerns.
Sincerely,
Diane K. Jorkasky, M.D., FACP
Senior Vice President Clinical
Development and Chief Medical
Officer
 |